A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.
Clinical trial NCT07180511 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07180511
- Sponsor
- E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2027-05-18
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.